Edition:
United States

Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

10.56EUR
15 Dec 2017
Change (% chg)

€-0.09 (-0.80%)
Prev Close
€10.65
Open
€10.72
Day's High
€10.81
Day's Low
€10.52
Volume
45,911
Avg. Vol
22,654
52-wk High
€11.20
52-wk Low
€8.41

Summary

Name Age Since Current Position

Barbara De Saedeleer

47 Non-Executive Chairman of the Board - Representing BDS Management BVBA

Francois Fornieri

Chief Executive Officer, Executive Director - Representative of YIMA SPRL

Christophe Marechal

2017 Chief Financial Officer

Herjan Bennink

Non-Executive Director

Marc Beyens

Non-Executive Director

Marc Coucke

52 Non-Executive Director - Representing Alychlo NV

Guy Debruyne

Non-Executive Director - Representing CG Cube SA

Marc Foidart

Non-Executive Director - Representing SC SCRL Investpartner

Freddy Meurs

Non-Executive Director - Representing CEFMA Consult SPRL

Gaetan Servais

Non-Executive Director - Representing Meusinvest SA

Jacques Platieau

Independent Director

Jean Sequaris

Independent Director

Philippe Suinen

Independent Director - Representing P. Suinen SPRL-S

Biographies

Name Description

Barbara De Saedeleer

Mrs. Barbara De Saedeleer is Non-Executive Chairman of the Board - Representing BDS Management BVBA of Mithra Pharmaceuticals SA. She is also Member of the Audit Committee of the Company. She graduated from Vlerick Business School with a degree in Marketing. She is Board Member of d'Aco Hud Nordic AB, AfriaMedic SA, Aurios Pty Ltd, Auragen Pyt Ltd, Chefaro Pharma Italia Srl and Jaico RDP NV, in addition to a number of other companies.

Francois Fornieri

Mr. Francois Fornieri is Chief Executive Officer, Executive Director - Representative of YIMA SPRL of Mithra Pharmaceuticals SA. He is Director at YIMA SPRL, Chief Executive Officer of Eole Racing Events SPRL and Board Member of Symbiose Biomaterials SA, as well as Semeb SA, Les Amis de M SCRL and Meusinvest SA, in addition to a number of other companies.

Christophe Marechal

Mr. Christophe Marechal has been appointed as Chief Financial Officer of the Company with effect from 23 February 2017. Mr Maréchal is currently Director, Group Treasury and Credit Risk Management, at Hamon Group (Euronext Brussels: HAMO), an engineering and contracting company. He has more than 20 years of financial experience in the international industrial, telecommunications, manufacturing and banking industries, including M&A, operational and financial strategy, and tactical initiatives to drive long-term business growth. Before joining Hamon Group in 2006, Mr Maréchal held a number of positions at France Telecom Group in Paris, London and Brussels, including Deputy Group Treasurer. He holds a Masters in Business Administration from the University of Liège, Belgium, and studied econometrics at the Katholieke Universiteit Brabant, Tilburg, Netherlands.

Herjan Bennink

Mr. Herjan Coelingh Bennink is Non-Executive Director of Mithra Pharmaceuticals SA. He founded Pantarhei Bioscience in 2001. In 2014, he created Pantarhei Oncology. He is CEO of Pantarhei Bioscience BV, Chairman of the Supervisory Board of Pantarhei Oncology BV and Chairman of the Board of Oxytone Bioscience BV.

Marc Beyens

Mr. Marc Beyens is Non-Executive Director of Mithra Pharmaceuticals SA. He graduated from Universite de Liege. He is also Board Member of Airwatec SA and LIG, as well as Member of the Management of Nethys SA.

Marc Coucke

Mr. Marc Coucke is Non-Executive Director - Representing Alychlo NV at Mithra Pharmaceuticals SA. He graduated from University of Gent (Pharmacy) and obtained an MBA degree from Vlerick Management School. He is CEO of Omega Pharma NV and Alychlo NV. He is also CEO and Board Member of Mylecke Management Art & Invest NV and Koninklijke Voetbalvereniging Oostende NV.

Guy Debruyne

Mr. Guy Debruyne is Non-Executive Director - Representing CG Cube SA of Mithra Pharmaceuticals SA. He is Board Member of Blue Star Invest SA, Standard Opportunities SA and CG Cube SA. He is also Board Member of Le Bocholtz SA and Fund SA.

Marc Foidart

Mr. Marc Foidart is Non-Executive Director - Representing SC SCRL Investpartner of Mithra Pharmaceuticals SA. He is also Chairman of Remuneration and Nominating Committees of the Company. He graduated from Universite de Liege. He is Board Member of Meusinvest SA, CEO of Spinventure SA and Board Member of Cide-Socran ASBL, in addition to a number of other companies.

Freddy Meurs

Mr. Freddy Meurs is Non-Executive Director - Representing CEFMA Consult SPRL of Mithra Pharmaceuticals SA. He has been Deputy Chief Executive Director of Meusinvest. He is also Board Member of CEFMA Consult SPRL, Advanced Mechanical and Optical Systems SA, NSI IT Software and Services SA and Samtech SA. He is also Chief Executive Officer of Lasea SA.

Gaetan Servais

Mr. Gaetan Servais is Non-Executive Director - Representing Meusinvest SA of Mithra Pharmaceuticals SA. He is a graduate of Universite de Liege. He is Chief Executive Officer of Meusinvest SA, Pole Image de Liege SA, Ateliers de la Meuse SA, Liege Airport Business Park SA, Namur Invest SA, as well as SNCB Logistics SA.

Jacques Platieau

Mr. Jacques Platieau is Independent Director of Mithra Pharmaceuticals SA. He is also Member of the Board of UWE ASBL and VOKA ASBL, as well as Chairman of SEV Network ASBL and Castors de Braine.

Jean Sequaris

Mr. Jean Sequaris is Independent Board Member of Mithra Pharmaceuticals SA. He is also Member of the Audit and Nominating Committees of the Company. He is Board Member of Wallimage Entreprises SA, CHU Liege, CHR Citadelle, ULG, Socofe SA, Eurogare SA and Sowalfin SA, as well as a number of other companies.

Philippe Suinen

Mr. Philippe Suinen is Independent Director - Representing P. Suinen SPRL-S of Mithra Pharmaceuticals SA. He is also Chairman of the Audit Committee and Member of the Nominating Committee of the Company. He graduated from Universite de Liege. He is CEO and Board Member of P. Suinen SPRL-S, and Board Member of Brussels South Charleroi Airport SA, La Malterie du Chateau SA and Jules Destree ASBL.